In acute myocardial infarction patients, does adding a traditional Chinese medicine compound to standard treatments improve outcomes?

Researchers investigated whether Tongxinluo, a Chinese medicinal compound, could improve clinical outcomes among ST-segment elevation myocardial infarction patients.

Nobel-winning AI was built on open science. Will the quest for profits quash collaboration?

The 2024 Nobel Prizes will be remembered as the year that artificial intelligence took the awards by storm. The physics prize this week was awarded

October 11, 2024

Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer’s Blood Test Assessed

Antibody response to anti-Epstein-Barr virus nuclear antigen 1 (EBNA-1) may be a risk factor for multiple sclerosis (MS), a small study suggested. (JAMA Neurology) ND0612,

March 20, 2024

Subcutaneous nivolumab revolutionizes renal cell carcinoma care with faster, easier treatment

Subcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and dramatically reduces treatment time in patients with renal cell carcinoma,

January 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.